Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05522075 · ClinicalTrials.gov registry record · NA
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
A NA study of Aging and Blood Pressure, sponsored by The University of Texas at Arlington.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05522075: Recruiting NA study of Aging and Blood Pressure, sponsored by The University of Texas at Arlington.
NCT05522075 is a NA study of Aging and Blood Pressure that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 55 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05522075, a NA study of Aging and Blood Pressure, is actively recruiting participants, sponsored by The University of Texas at Arlington.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
This study has two phases: Phase 1 is to examine blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers vs. alcohol abstainers/moderate drinkers. Phase 2 is to examine the effect of 8-week aerobic exercise training on blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers
Primary Outcome
Recruitment capacity (e.g., how many subjects respond and enter to the study or reasons of refusal), resulting subject characteristics, the number of exercise session attended, and the number of dropouts
Conditions Studied
Interventions
- BEHAVIORAL Exercise Training
- BEHAVIORAL Alcohol Abstinence Intervention
Study Locations (1)
Texas
- University of Texas at Arlington - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT05522075 shows while recruiting
NCT05522075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).
The record links to 8 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Exercise Training is the first listed.
NCT05522075 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05522075 about?
NCT05522075 is a clinical study titled "Reducing Blood Pressure in Mid-life Adult Binge Drinkers". This study has two phases: Phase 1 is to examine blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers vs. alcohol abstainers/moderate drinkers. Phase 2 is to examine the effect of 8-week aerobic exercise training on blood pressure, microvascular f...
What is the current status of trial NCT05522075?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2022-11-21. Estimated completion is 2026-04-30.
What conditions does trial NCT05522075 study?
This clinical trial studies the following conditions: Aging, Blood Pressure, Alcohol Drinking, Lifestyle Factors, Vasodilation.
What interventions are being tested in trial NCT05522075?
The interventions under investigation include: Exercise Training (BEHAVIORAL), Alcohol Abstinence Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05522075?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05522075 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05522075's enrollment target sits among peer trials
55 149th of 262 higher than 113 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI